- Supriya Lifescience Ltd is available at good price which is above 60 RSI.
- Excellent Q42025 results Increase in 16 % YOY
- Export contribution to total revenue increased to 85%, up from 74% in the same quarter last year.
- LATAM region contributed 21% to total revenue this quarter, compared to 8% in the same quarter last year, indicating strong growth in regulated markets.
- Anticipating a significant contribution from CMO and CDMO business segments, particularly leveraging the China+1 strategy.
- Supriya LIfescience 28 May 25
BUY : SUPRIYA-EQ( SUPRIYA ) [7390]
—
by